Clinical trial
A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus…
NCT00288470 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00288470 |
|---|---|
| Title | A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast. |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Facial Wrinkles |
| Intervention type | Device |
| Interventions | Hylaform, Hylaform Plus (hylan B gel) |
| Start date | Jun 1, 2002 |
| Completion | Aug 1, 2003 |
| First posted | Feb 8, 2006 |
| Last update posted | Mar 18, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: